From July 22nd to 26th, the 25th International AIDS Conference (AIDS 2024) was held in Munich, Germany. As the largest global conference on AIDS, it brought together medical companies, experts, scholars, and professionals from around the world to discuss the latest advancements and future challenges in HIV/AIDS prevention and treatment. As a global leader in AIDS and STI diagnostics, InTec PRODUCTS, INC. attended the conference.

The AIDS epidemic continues to spread in all countries around the world, and the task of HIV/AIDS prevention and control remains challenging. The United Nations General Assembly's "Political Declaration on Ending AIDS by 2030" sets the "95-95-95" targets: 95% of people living with HIV should know their status, 95% of diagnosed individuals should receive antiretroviral therapy, and 95% of people on treatment should have suppressed viral loads.

To actively promote early diagnosis and linkages to treatment and prevention measures for HIV/AIDS, InTec has been committed to innovating and upgrading our HIV/AIDS products for many years. In regions with high HIV/AIDS prevalence, particularly in Africa, we have tailored our products to the local healthcare system and economic conditions to provide cost-effective solutions. Currently, our products have been exported to over 30 African countries, including South Africa, Ethiopia, Algeria, and Egypt. The number of HIV/AIDS exports to the South African market alone has exceeded 100 million.

With excellent product performance, our HIV/AIDS products have not only become the "gold standard" for HIV testing in numerous countries and regions in Africa but have also obtained international authoritative certifications such as WHO PQ and CE and are included in the WHO list of recommended in vitro diagnostic procurement. In the WHO product performance evaluation, our One Step Anti-HIV (1&2) Test have demonstrated 100% sensitivity and specificity.

In the future, InTec will continue to contribute to the timely achievement of the global HIV/AIDS "95-95-95" targets and remain committed to addressing public health and basic healthcare needs. We will continuously improve the usability and accessibility of our products, serve the global healthcare system with cost-effective solutions, contribute the power of InTec, and drive global medical accessibility and well-being.